Moderna to Host Investor Event - Analyst Day
Rhea-AI Summary
Moderna (Nasdaq: MRNA) will host an Investor Event - Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025.
Management will present on Moderna's development and commercial strategy and key business considerations. A live webcast will be available at investors.modernatx.com under Events and Presentations. A replay will be archived on Moderna's website for at least 30 days following the presentation.
Positive
- None.
Negative
- None.
News Market Reaction 4 Alerts
On the day this news was published, MRNA declined 2.23%, reflecting a moderate negative market reaction. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $239M from the company's valuation, bringing the market cap to $10.49B at that time.
Data tracked by StockTitan Argus on the day of publication.
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025.
The event will include presentations from management discussing Moderna's development and commercial strategy and key business considerations.
A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website
Webcast: investors.modernatx.com.
A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including pioneering work on COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Media Contacts
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
FAQ
When is Moderna's (MRNA) Investor Event - Analyst Day in 2025?
How can investors watch the Moderna (MRNA) Analyst Day webcast?
Will Moderna (MRNA) post a replay of the November 20, 2025 Analyst Day?
What topics will Moderna (MRNA) cover at the November 20, 2025 Analyst Day?
Where in the Moderna (MRNA) investor site is the Analyst Day webcast available?
